Metaraminol bitartrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for metaraminol bitartrate and what is the scope of patent protection?
Metaraminol bitartrate
is the generic ingredient in two branded drugs marketed by Merck, Abraxis Pharm, Azurity, Elkins Sinn, Fresenius Kabi Usa, and Gd Searle Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Summary for metaraminol bitartrate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 6 |
| NDAs: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 627 |
| What excipients (inactive ingredients) are in metaraminol bitartrate? | metaraminol bitartrate excipients list |
| DailyMed Link: | metaraminol bitartrate at DailyMed |
Medical Subject Heading (MeSH) Categories for metaraminol bitartrate
Anatomical Therapeutic Chemical (ATC) Classes for metaraminol bitartrate
US Patents and Regulatory Information for metaraminol bitartrate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 086418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 211304-001 | Aug 24, 2021 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080722-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abraxis Pharm | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080431-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
